2007
DOI: 10.1158/0008-5472.can-06-3963
|View full text |Cite
|
Sign up to set email alerts
|

Elevated Interleukin-6 and G-CSF in Human Pancreatic Cancer Cell Conditioned Medium Suppress Dendritic Cell Differentiation and Activation

Abstract: Although dendritic cell (DC) function is impaired in pancreatic cancer patients, the underlying mechanisms are unknown. This study analyzed the soluble factors released by pancreatic cancer cells responsible for inhibiting DC differentiation and activation. Medium conditioned by a highly metastatic human pancreatic cancer cell line BxPC-3 [BxPC-3 conditioned medium (BxCM)] was mainly used for the study. Both CD34 + hematopoietic progenitor cell-derived and CD14 + monocyte-derived immature DCs and mature DCs (m… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
94
1
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 134 publications
(100 citation statements)
references
References 45 publications
4
94
1
1
Order By: Relevance
“…These factors are highly expressed in RCC 5,48 and may thus promote the differentiation of ercDCs in situ. The identification of these factors was based on a study design that was distinct from those reported by others 37,49,50 : cultivation supplements, IL-4, or GM-CSF, which are commonly used to differentiate DCs in vitro but do not represent a DC differentiation pathway in vivo, 12 were deliberately omitted. Thus, we believe that the used cultivation system better reflected the natural process of monocyte differentiation when entering the tissue milieu.…”
Section: Discussionmentioning
confidence: 99%
“…These factors are highly expressed in RCC 5,48 and may thus promote the differentiation of ercDCs in situ. The identification of these factors was based on a study design that was distinct from those reported by others 37,49,50 : cultivation supplements, IL-4, or GM-CSF, which are commonly used to differentiate DCs in vitro but do not represent a DC differentiation pathway in vivo, 12 were deliberately omitted. Thus, we believe that the used cultivation system better reflected the natural process of monocyte differentiation when entering the tissue milieu.…”
Section: Discussionmentioning
confidence: 99%
“…While promoting macrophage enrichment, pancreatic cancer cells have been shown to inhibit dendritic cells differentiation via secretion of IL-6 and G-CSF 36 .…”
Section: Tumour-educated Macrophages and Hyperglycaemia Promote Invasmentioning
confidence: 99%
“…They found that one of the soluble factors released by pancreatic cancer cells and being responsible for inhibiting DC differentiation and activation is IL-6; more recently, Tjomsland et al (64) evidenced the implication of the inflammatory factor PGE 2 in patients with ductal pancreatic adenocarninoma, causing semimature blood DC. Thus, the immunosuppressive microenvironment created by tumors themselves through the release of soluble factors renders DC tolerant (63)(64)(65). At present, we do not know whether IL-8-and IL-6-secreting (but not IL-10) pBSDL-J28 mature MoDC could be generated in vivo and take part in the suppressor environment within tumoral and inflammatory pancreas.…”
Section: Discussionmentioning
confidence: 96%